UP!

ZGNX $26.68

ZGNX target price
26.68
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2022 2022-05-04 Future report Set alerts
Q4 2021 2022-02-28 -0.98 -0.98
Q3 2021 2021-11-04 -1.04 -1.04
Q2 2021 2021-08-05 0.00 0.00
Q1 2021 2021-05-06 -1.00 -1.00
Q4 2020 2021-02-25 -1.26 -1.26
Q3 2020 2020-11-09 0.00 0.00
Q2 2020 2020-08-05 -0.96 -0.96
Q1 2020 2020-05-05 -0.54 -0.54
Q4 2019 2020-03-02 -1.26 -1.26

Ratings

2016-05-11 Reiterated Rating Brean Capital Buy $28.00
2016-04-27 Reiterated Rating Brean Capital Buy $28.00
2016-03-11 Reiterated Rating Brean Capital Buy $28.00
2015-12-15 Reiterated Rating Brean Capital Buy
2015-11-27 Reiterated Rating Leerink Swann Outperform $26.00
2015-11-11 Reiterated Rating Brean Capital Buy $28.00
2015-11-10 Initiated Coverage William Blair Hold
2015-11-10 Lower Price Target Leerink Swann Outperform $27.00 to $26.00
2015-10-21 Reiterated Rating Oppenheimer Buy $23.00
2015-10-21 Reiterated Rating Oppenheimer Holdings Inc. Buy $23.00
2015-10-06 Reiterated Rating Leerink Swann Outperform
2015-10-01 Reiterated Rating Brean Capital Buy
2015-09-17 Reiterated Rating Brean Capital Buy $28.00
2015-08-14 Reiterated Rating Brean Capital Buy $28.00
2015-08-11 Reiterated Rating Leerink Swann Outperform
2015-08-11 Reiterated Rating William Blair Hold
2015-06-15 Reiterated Rating Brean Capital Buy $2.50
2015-05-28 Set Price Target Brean Capital Buy $2.50
2015-05-12 Reiterated Rating Oppenheimer Outperform $2.50
2015-04-29 Set Price Target Brean Capital Positive to Buy $2.50
2015-04-21 Initiated Coverage Piper Jaffray Overweight $2.50
2015-04-21 Initiated Coverage Piper Jaffray Cos. Overweight $2.50
2015-03-11 Downgrade William Blair Outperform to Market Perform
2015-01-20 Reiterated Rating Brean Capital Buy
2014-12-29 Initiated Coverage Brean Capital Buy $2.50
2014-08-06 Lower Price Target Leerink Swann $3.90 to $3.00
2014-08-06 Lower Price Target Oppenheimer Outperform $5.00 to $2.50
2014-08-05 Reiterated Rating William Blair Outperform $5.00 to $3.00
2014-07-25 Reiterated Rating Stifel Nicolaus Buy $5.00 to $3.50
2014-06-06 Initiated Coverage R. F. Lafferty Buy $3.50
2014-05-12 Reiterated Rating William Blair Outperform $6.00 to $5.00
2014-04-25 Reiterated Rating Stifel Nicolaus Buy $5.00
2013-11-14 Upgrade Oppenheimer Market Perform to Outperform $5.00
2013-10-29 Upgrade Stifel Nicolaus Hold to Buy $5.00
2013-10-28 Boost Price Target William Blair Outperform $3.00 to $6.00
2013-03-05 Initiated Brinson Patrick Market Outperform
2012-12-10 Downgrade Oppenheimer Outperform to Perform $3
2011-09-26 Reiterated Oppenheimer Outperform $9 to $5
2016-05-11 Reiterated Rating Brean Capital Buy $28.00
2016-04-27 Reiterated Rating Brean Capital Buy $28.00
2016-03-11 Reiterated Rating Brean Capital Buy $28.00
2015-12-15 Reiterated Rating Brean Capital Buy
2015-11-27 Reiterated Rating Leerink Swann Outperform $26.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
DOMAIN PARTERS VII L P 7.04%  (9923335) AKAO / CADX / CLVS / ESPR / EVOK / OREX / RGDO / TNDM / ZGNX /
Clarus Lifesciences I, L.P. 6.72%  (9482439) AVNR / GMED / OXFD / ZGNX /
WHEELER KURT 4.24%  (5982439) GMED / ZGNX /
Scale Venture Partners II, LP Former 10% Holder 3.77%  (5321546) ZGNX /
PERCEPTIVE ADVISORS LLC 2.81%  (3970357) ACRX / AEGR / ALDX / BIOD / FOLD / LJPC / PLCC / RPRX / VSAR / ZGNX /
FARR STEPHEN J President and COO 0.64%  (902209) ZGNX /
RHOADS ANN D EVP, CFO, Treasurer & Sec. 0.33%  (469980) EVOK / GMED / IRIX / ZGNX /
Shively Richard Scott Chief Commercial Officer 0.25%  (358771) DEPO / ZGNX /
GARNER CAM L 0.23%  (326750) CADX / EVOK / ZGNX /
Halak Brian K 0.12%  (169251) ACHN / AKAO / ALIM / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / TNDM / VCYT / VNDA / ZGNX /
DOVEY BRIAN H 0.12%  (169251) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / OTIC / RGDO / TNDM / VCYT / ZGNX /
SCHOEMAKER KATHLEEN K 0.12%  (169251) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
BLAIR JAMES C 0.12%  (169251) ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
VITULLO NICOLE 0.12%  (169251) ACHN / AKAO / CADX / CLVS / CPXX / DRNA / DRTX / ESPR / EVOK / MRNS / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
TREU JESSE I 0.12%  (169251) ACHN / AKAO / ALDX / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX /
DP VII ASSOCIATES LP 0.12%  (169251) AKAO / CADX / CLVS / ESPR / EVOK / OREX / TNDM / ZGNX /
HAWLEY ROGER Chief Executive Officer 0.06%  (90575) CERU / TGEN / ZGNX /
Robinson Cynthia Y Chief Development Officer 0.04%  (52746) ZGNX /
MAST ERLE T 0.02%  (24221) CLVS / RCPT / ZGNX /
Haas Ken 0.01%  (19849) ZGNX /
TANNENBAUM RENEE P 0.01%  (10000) SMED / ZGNX /
Domain Partners VI, L.P. 0.01%  (9894) ALDX / ALIM / CADX / MRNS / OCRX / RGDO / ZGNX /